Biogen's injectable MS drug cut relapse rate by 36 pct

* Plegridy cut proportion of patients who relapsed by 39 pct
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.